Headlands Technologies LLC Buys Shares of 434 Chemed Co. (NYSE:CHE)

Headlands Technologies LLC purchased a new position in Chemed Co. (NYSE:CHE) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 434 shares of the company’s stock, valued at approximately $230,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Norges Bank bought a new position in Chemed in the fourth quarter worth about $95,872,000. Raymond James Financial Inc. acquired a new position in Chemed in the fourth quarter valued at approximately $42,023,000. Principal Financial Group Inc. increased its holdings in shares of Chemed by 114.1% during the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company’s stock valued at $39,554,000 after purchasing an additional 39,791 shares in the last quarter. Segall Bryant & Hamill LLC acquired a new position in shares of Chemed in the 4th quarter valued at $12,880,000. Finally, Boston Trust Walden Corp boosted its holdings in Chemed by 10.0% during the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company’s stock worth $128,303,000 after buying an additional 22,105 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Chemed Price Performance

Shares of NYSE:CHE opened at $598.17 on Friday. The business’s 50 day moving average price is $580.24 and its 200-day moving average price is $568.11. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $632.53. The firm has a market capitalization of $8.76 billion, a price-to-earnings ratio of 30.23, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed’s dividend payout ratio (DPR) is 10.05%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on CHE shares. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th. Royal Bank of Canada upped their price target on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the sale, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.